Tech Company Financing Transactions
Landos Biopharma Funding Round
Perceptive Advisors and private investors invested in a $10 million Series A capital raise for Landos Biopharma. The round was recorded on 9/22/2017.
Transaction Overview
Company Name
Announced On
9/22/2017
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Perceptive Advisors (Lead Investor) (Joe Edelman)
Proceeds Purpose
With the Series A investment, Landos plans to complete remaining IND-enabling studies, file an IND for BT-11 in 2018 and expects to complete Phase 1 clinical testing by early 2019.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1800 Kraft Dr. 216
Blacksburg, VA 24060
USA
Blacksburg, VA 24060
USA
Phone
Undisclosed
Website
Email Address
Overview
Landos' unique core platform technology enables accelerated development of safer, more effective oral, first-in-class therapeutics for autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Josep Bassaganya-Riera
Chief Medical Officer
Simon Lichtiger
Chief Scientific Officer
Raquel Hontecillas
Chief Scientific Officer
Andrew Leber
VP - Finance
Jennifer Collette
VP - Regulatory Affairs
Jyoti Chauhan
Browse more venture capital transactions:
Prev: 9/22/2017: Verkada venture capital transaction
Next: 9/25/2017: ProctorFree venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs